Skip to main content

Advertisement

Log in

A review on efforts for improvement in medicinally important chemical constituents inAconitum through biotechnological interventions

  • Review Article
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

The genus Aconitum belongs to the family Ranunculaceae, is endowed with more than 350 species on the earth. Medicinally important aconitine type of diterpenoid alkaloids are the characteristic compounds in most of the Aconitum species. The present review endeavored the major research carried out in the field of genetic resource characterization, pharmacological properties, phytochemistry, major factors influencing quantity, biosynthetic pathways and processing methods for recovery of active ingredients, variety improvement, propagation methods, and important metabolite production through cell/organ culture of various Aconitum species. More than 450 derivatives of aconitine-type C19 and C20-diterpenoid alkaloids along with a few other non-alkaloidal compounds, such as phenylpropanoids, flavonoids, terpenoids, and fatty acids, have been identified in the genus. A few Aconitum species and their common diterpenoid alkaloid compounds are also well characterized for analgesic, inflammatory and cytotoxic properties. However, the different isolated compound needs to be validated for supporting other traditional therapeutical uses of the plant species. Aconitine alkaloids shared common biosynthesis pathway, but their diversification mechanism remains unexplored in the genus. Furthermore, the process needs to be developed on secondary metabolite recovery, mass-scale propagation methods, and agro-technologies for maintaining the quality of products. Many species are losing their existence in nature due to over-exploitation or anthropogenic factors; thus, temporal monitoring of the population status in its habitat, and suitable management programs for ascertaining conservation needs to be developed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability statement

Authors confirmed that no primary or secondary data was used in this review.

References

Download references

Acknowledgements

SR thanks Director GBPNIHE for providing facilities and encouragement. This work received partial financial support from the Institute as In-house Project No-04.

Funding

MoEF&CC (Project number 02).

Author information

Authors and Affiliations

Authors

Contributions

SR and ST conceived the idea and designed the study. ST, PK, BS, AKP, and SR compiled the database and wrote the manuscript. All authors contributed to the editing and critical revision of the manuscript.

Corresponding author

Correspondence to Sandeep Rawat.

Ethics declarations

Conflict of interest

The authors declared that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tiwari, S., Acharya, P., Solanki, B. et al. A review on efforts for improvement in medicinally important chemical constituents inAconitum through biotechnological interventions. 3 Biotech 13, 190 (2023). https://doi.org/10.1007/s13205-023-03578-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-023-03578-z

Keywords

Navigation